NCT04744168

Brief Summary

Brief Summary Short description of the protocol intended for the lay public. Include a brief statement of the study hypothesis. (Limit: 5000 characters) Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). The first purpose of this randomized study is to determine if five points of acupuncture : 4GI, 6RP, 34VB, 36E, 3F could improve the bishop score for prolonged pregnancies and decrease the rate of maturation. The protocol of our study consists of proposing to the pregnant women one or two acupuncture sessions the term's day and three days later. Once the consent is signed, women are randomly included in the experimental or placebo arm. In the experimental arm, midwives puncture five points : 4GI, 6 RP, 34VB, 36E, 3F on each side while in the placebo arm, they puncture just one point : 16 HM on each side. The maturation's rate between the two groups will be compared by a Fisher's exact test and analyzed in function parity (nulliparous or multiparous) and number of sessions (one or two) with a model of univariate and multivariate logistic regression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 8, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

March 9, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2021

Completed
Last Updated

September 22, 2021

Status Verified

September 1, 2021

Enrollment Period

6 months

First QC Date

January 22, 2021

Last Update Submit

September 21, 2021

Conditions

Keywords

Bishop's scoreMaturationAcupuncturePregnancy

Outcome Measures

Primary Outcomes (3)

  • Bishop score

    cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required (The highest possible score is 13 and the lowest possible score is 0)

    At 41 weeks of amenorrhea

  • Bishop score

    cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required

    3 days after the term of pregnancy

  • Bishop score

    cervix score is a pre-labor scoring system to assist in predicting whether induction of labor will be required

    5 days after the term of pregnancy

Secondary Outcomes (4)

  • Rate spontaneous labour

    At 41 weeks 5 days of amenorrhea

  • Duration labor

    At 41 weeks 5 days of amenorrhea

  • Rate of delivery with medical intervention

    At 41 weeks 5 days of amenorrhea

  • Rate of delivery by cesarean

    At 41 weeks 5 days of amenorrhea

Study Arms (2)

Acupuncture

EXPERIMENTAL

In the experimental arm, pregnant women at term will benefit one or two acupuncture sessions with five points : 4GI, 6RP, 34VB,36E,3F. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.

Other: Acupuncture

Placebo acupuncture

PLACEBO COMPARATOR

In the placebo arm, pregnant women will benefit one or two acupuncture sessions with one point which is located outside the acupuncture meridian. The first session at 41 amenorrhea weeks and the second at 41 amenorrhea weeks and 3 days if they are not delivered between the both.

Other: Placebo Acupuncture

Interventions

Puncture of 5 points 4GI, 6RP, 34VB, 36E, 3F

Acupuncture

Puncture of point HM

Placebo acupuncture

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Nulliparous or multipares with physiological pregnancy at 41 weeks
  • Cephalic foetal presentation,
  • Healthy or unicicatricial uterus,
  • Major patientes,
  • Speaking french,
  • Term of the pregnancy determinated with a dating ultrasound between 11 weeks and 13 weeks+ 6 days,
  • Having signed the form of consent participation.

You may not qualify if:

  • Foetal or maternal diseases requiring a maturation before 41 weeks : pre eclampsia, pre-existing diabetes, imbalance gestational diabetes, threat premature delivery treat with tocolytic, macrosomia or intrauterine growth retardation,
  • Diseases discoveries at 41 weeks : pre eclampsia, moves of the baby decrease, low amniotic fluid,anomalies of the foetal heartbeat
  • Circled pregnancy,
  • Twins or more,
  • Foetal death in utero, medical termination of pregnancy,
  • Unstuck membranes,
  • Minor patients
  • Patients who benefited acupuncture during pregnancy ,
  • Imprecise term of delivery,
  • Podalic presentation
  • Patients under supervision or curatorship,
  • Patients without social security.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, 91106, France

Location

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Women will be distributed randomly in the experimental or the placebo arm. They won't know that the point 16 HM isn't effective on cervix maturation. They will believe that both techniques work.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2021

First Posted

February 8, 2021

Study Start

March 9, 2021

Primary Completion

September 16, 2021

Study Completion

September 16, 2021

Last Updated

September 22, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations